Home Commercial Epicrispr Biotechnologies Renews 25,000 SQFT at 7000 Shoreline Court in South San Francisco
CommercialINDUSTRY newsLeasingLife Science

Epicrispr Biotechnologies Renews 25,000 SQFT at 7000 Shoreline Court in South San Francisco

Share
Aerial view of south San Francisco bay area, Milpitas, California
Photo by Sundry Photography on iStock
Share

The epigenetic medicine company anchors its Peninsula headquarters as the Bay Area life sciences market navigates a gradual recovery. Epicrispr Biotechnologies, the CRISPR-pioneer-founded epigenetic medicine company known commercially as Epic Bio, renewed its 24,780-square-foot lease at 7000 Shoreline Court in South San Francisco during the first quarter of 2026, according to CBRE's Q1 2026 San […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

University of California Acquires 261-Room Ritz-Carlton Half Moon Bay for $193MM From Strategic Hotels

The University of California's investment office has taken over the Ritz-Carlton Half...

Stanford Health Care Renews 35,000 SQFT at 867 American Street in San Carlos as Class A Vacancy Hits 69%

Stanford Health Care has renewed its 35,000-square-foot lease at 867 American Street...

Project Uris Buys 75,000 SQFT 47 Kearny and 165 Post in San Francisco’s Union Square for $19.6MM

Uris Acquisitions, the Union Square buying vehicle of Ian Jacobs and Max...

Block Puts Entire 361,000 SQFT Uptown Station Headquarters in Oakland on the Sublease Market

Seven months after cutting nearly half its workforce, payments company Block has...